Discovery and lead identification of quinazoline-based BRD4 inhibitors.

Therapeutic Approaches

Abstract

A new series of quinazoline-based analogs as potent bromodomain-containing protein 4 (BRD4) inhibitors is described. The structure-activity relationships on 2- and 4-position of quinazoline ring, and the substitution at 6-position that mimic the acetylated lysine are discussed. A co-crystallized structure of 48 (CN750) with BRD4 (BD1) including key inhibitor-protein interactions is also highlighted. Together with preliminary rodent pharmacokinetic results, a new lead (65, CN427) is identified which is suitable for further lead optimization.

Authors

Yang, Shyh Ming; Urban, Daniel; Yoshioka, Makoto; Strovel, Jeffrey W; Fletcher, Steven; Wang, Amy; Xu, Xin; Shah, Pranav; Hu, Xin; Hall, Matthew; Jadhav, Ajit; Maloney, David J;

External Links